SCHEMBL6635082

SCHEMBL6635082

C=CS(=O)(=O)N1Cc2cc(C#N)ccc2NCC1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 12/20 0.46
▸ FNTB P49356 12/20 0.46
▸ HRAS P01112 1/20 0.42
▸ KRAS P01116 1/20 0.42
▸ PGGT1B P53609 1/20 0.42
▸ PSEN1 P49768 2/20 0.34
▸ PSEN2 P49810 2/20 0.34
▸ APH1B Q8WW43 2/20 0.34
▸ NCSTN Q92542 2/20 0.34
▸ APH1A Q96BI3 2/20 0.34
▸ PSENEN Q9NZ42 2/20 0.34
▸ NAMPT P43490 1/20 0.33
▸ TNKS O95271 1/20 0.33
▸ NR3C2 P08235 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ MGLL Q99685 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635074 1.00 FNTA (0.46) FNTAFNTBHRASKRASPGGT1B
SCHEMBL7677686 0.87 FNTA (0.58) FNTAFNTBHRASKRASPGGT1B
SCHEMBL6615552 0.87 FNTA (0.47) FNTAFNTBHRASKRASPGGT1B
SCHEMBL6615549 0.87 FNTA (0.47) FNTAFNTBHRASKRASPGGT1B
SCHEMBL6630924 0.87 FNTA (0.58) FNTAFNTBHRASKRASPGGT1B
SCHEMBL7666114 0.87 FNTA (0.47) FNTAFNTBHRASKRASPGGT1B
SCHEMBL5787326 0.86 FNTA (0.59) FNTAFNTBHRASKRASPGGT1B
SCHEMBL5787316 0.86 FNTA (0.59) FNTAFNTBHRASKRASPGGT1B
SCHEMBL6615294 0.85 FNTA (0.43) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL6630047 0.85 PSEN1 (0.43) FNTAFNTBPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481975-A1 Inhibitors of farnesyl protein transferase BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-01 — — EP disclosed
US-6458783-B1 INHIBITION OF FARNESYL TRANSFERASE, WHICH IS AN ENZYME INVOLVED IN RAS ONCOGENE EXPRESSION, IS EFFECTED BY COMPOUNDS OF THE FORMULAS OF BENODIAZEPINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY 2002-10-01 — — US disclosed
US-6455523-B1 ADMINISTERING 1,4-BENZODIAZEPINE DERIVATIVE AS ANTITUMOR OR ANTICARCINOGENIC AGENT BRISTOL-MYERS SQUIBB COMPANY 2002-09-24 — — US disclosed
WO-2001081322-A1 NON-IMIDAZOLE BENZODIAZEPINE INHIBITORS OF FARNESYL PROTEIN TRANSFERASE BRISTOL-MYERS SQUIBB COMPANY (US) 2001-11-01 — — WO disclosed
US-6011029-A BENZODIAZEPINE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-01-04 — — US disclosed
Send feedback